Poseida’s Myeloma-specific CAR T-cells Combat Aggressive Cancer in Mice, Study Shows – Myeloma Research News
Myeloma Research News |
Poseida’s Myeloma-specific CAR T-cells Combat Aggressive Cancer in Mice, Study Shows
Myeloma Research News Poseida Therapeutics demonstrated that their new CAR T-cell treatment for multiple myeloma — P-BCMA-101 — possessed features that make it stand out in the field of gene-edited cancer cell therapies. The preclinical data, presented at the CAR-TCR … |
The Hindu |
India, Japan sign pact on stem cell research
The Hindu In the light of Japan’s Prime Minister Shinzo Abe’s visit to India, the two countries have signed a host of agreements on Wednesday to further cooperation in science and technology, including research into stem–cells for making bone-marrow transplants … |
The Hindu |
India, Japan sign pact on stem cell research
The Hindu In the light of Japan’s Prime Minister Shinzo Abe’s visit to India, the two countries have signed a host of agreements on Wednesday to further cooperation in science and technology, including research into stem–cells for making bone-marrow transplants … |
PhillyVoice.com |
Temple gifted $11.6 million grant to explore stem cell solutions to …
PhillyVoice.com Temple University was awarded an $11.6 million grant from the National Institutes of Health to help scientists pursue heart disease solutions created by stem … NIH grant supports temple researchers’ exploration of stem cell …News-Medical.net Temple scientists land $11.6M grant to study stem cell-based heart …Philadelphia Business Journal |
|
Combination Immunotherapy Improves Kidney Cancer Survival
Newswise (press release) 12, 2017 – A combination immunotherapy treatment showed better overall survival in patients with previously untreated advanced or metastatic renal cell carcinoma than current therapy, according to results from a phase 3 clinical trial presented at the … |
|
Combination Immunotherapy Improves Kidney Cancer Survival
Newswise (press release) 12, 2017 – A combination immunotherapy treatment showed better overall survival in patients with previously untreated advanced or metastatic renal cell carcinoma than current therapy, according to results from a phase 3 clinical trial presented at the … |
|
Combination Immunotherapy Improves Kidney Cancer Survival
Newswise (press release) 12, 2017 – A combination immunotherapy treatment showed better overall survival in patients with previously untreated advanced or metastatic renal cell carcinoma than current therapy, according to results from a phase 3 clinical trial presented at the … |